The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume -, Issue -, Pages 1-9
Publisher
IOS Press
Online
2020-02-26
DOI
10.3233/jad-191227
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical diagnoses among individuals with primary age-related tauopathy versus Alzheimer’s neuropathology
- (2019) Merilee Teylan et al. LABORATORY INVESTIGATION
- Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes
- (2019) Tiziana Carandini et al. Alzheimers Research & Therapy
- The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable
- (2018) David S. Knopman et al. Alzheimers & Dementia
- The A/T/N biomarker scheme and patterns of brain atrophy assessed in mild cognitive impairment
- (2018) Urban Ekman et al. Scientific Reports
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Suspected non-Alzheimer disease pathophysiology — concept and controversy
- (2016) Clifford R. Jack et al. Nature Reviews Neurology
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Cerebrospinal Fluid Levels of Amyloid Beta 1–43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer’s Disease: A 2-Year Follow-Up Study
- (2016) Camilla Lauridsen et al. Frontiers in Aging Neuroscience
- PART is part of Alzheimer disease
- (2015) Charles Duyckaerts et al. ACTA NEUROPATHOLOGICA
- Apolipoprotein E 2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
- (2014) G. Berge et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- (2014) A. M. Fagan et al. Science Translational Medicine
- Pre-analytical factors influencing the stability of cerebrospinal fluid proteins
- (2013) Anja H. Simonsen et al. JOURNAL OF NEUROSCIENCE METHODS
- Mild cognitive impairment—amyloid and beyond
- (2013) Philip Scheltens Nature Reviews Neurology
- Aβ-independent processes—rethinking preclinical AD
- (2013) Gaël Chételat Nature Reviews Neurology
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started